Erasmus School of Health Policy & Management
PhD candidate | Health Technology Assessment (HTA)
- xander@eshpm.eur.nl
- Room
- J8-55
- Location
- Burg. Oudlaan 50, Rotterdam
More information
Work
- Brenda Leeneman, Nicolas S.H. Xander, W. Edward Fiets, Wouter K. de Jong, Nathalie E.M. Uyl, A. N.Machteld Wymenga, An K.L. Reyners & Carin A. Uyl-de Groot (2024) - Assessing the clinical benefit of systemic anti-cancer treatments in the Netherlands: The impact of different thresholds for effectiveness - European Journal of Cancer, 202 - doi: 10.1016/j.ejca.2024.114002 - [link]
- Nicolas S.H. Xander, W. Edward Fiets & Carin A. Uyl-de Groot (2023) - Cost-effectiveness and budget impact of pembrolizumab+axitinib versus sunitinib in patients with advanced clear-cell renal cell carcinoma in the Netherlands - Frontiers in Oncology, 13 - doi: 10.3389/fonc.2023.1205700 - [link]
Master Thesis HE
- Year Level
- master, master
- Year
- 2023
- Course Code
- GW4592M
Health Technology Assessment
- Year Level
- master, master, master
- Year
- 2023
- Course Code
- GW4546M
Master Thesis HEPL
- Level
- master
- Year Level
- master
- Year
- 2023
- Course Code
- GW4555M
Pharmaceutical Pricing and Market Access
- Year Level
- master, master, master, master
- Year
- 2023
- Course Code
- GW4575M